Incannex Healthcare Limited carries a market capitalization of 46.78M, placing it among publicly traded companies globally. Its enterprise value stands at -24.57M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 46.78M |
| Enterprise Value | -24.57M |
Incannex Healthcare Limited currently has 13.68M shares outstanding.
| Shares Outstanding | 13.68M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.29 |
| P/TBV Ratio | 0.66 |
| P/FCF Ratio | -3.07 |
| P/OCF Ratio | -3.06 |
| EV / Sales | 12,069.81 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Incannex Healthcare Limited maintains a current ratio of 41.56, meaning it holds 41.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 41.56 |
| Quick Ratio | 41.47 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | -0.01 |
| Interest Coverage | N/A |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -34.85 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Incannex Healthcare Limited's stock has declined approximately -38.03011% over the past 52 weeks. The 50-day moving average sits at 3.77, while the 200-day moving average is 8.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -38.03011% |
| 50-Day Moving Average | 3.77 |
| 200-Day Moving Average | 8.00 |
| Average Volume (20 Days) | N/A |
EBITDA reached -16.69M, while operating income came in at -16.88M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -16.88M |
| Pretax Income | -16.81M |
| Net Income | -16.81M |
| EBITDA | -16.69M |
| EBIT | -16.88M |
| Earnings Per Share (EPS) | -1.47 |
Incannex Healthcare Limited holds 74.45M in cash and equivalents against 114,000.00 in total debt, resulting in a net debt position of -74.45M. Total book value stands at -174.33M, with working capital of 78.17M providing operational flexibility.
| Cash & Cash Equivalents | 74.45M |
| Total Debt | 114,000.00 |
| Net Debt | -74.45M |
| Equity (Book Value) | -174.33M |
| Book Value Per Share | -15.23 |
| Working Capital | 78.17M |
Incannex Healthcare Limited produced -16.24M in operating cash flow over the past twelve months. After subtracting -11,000.00 in capital expenditures, free cash flow totaled -16.25M - equivalent to -1.42 per share.
| Operating Cash Flow | -16.24M |
| Capital Expenditures | -11,000.00 |
| Free Cash Flow | -16.25M |
| FCF Per Share | -1.42 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -146.30 |
| FCF Yield | -32.61 |
Incannex Healthcare Limited's most recent stock split took place on February 27, 2026 with a 30:1 split ratio.
| Last Split Date | 2/27/2026 |
| Split Ratio | 30:1 |
Incannex Healthcare Limited posts an Altman Z-Score of 3.35, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.35 |